Prospective Study of Guideline ‐Tailored Therapy with Direct‐Acting Antivirals for Hepatitis C Virus‐Associated Mixed Cryoglobulinemia

Conclusion: interferon‐free, guideline‐tailored therapy with DAA is highly effective and safe for HCV‐associated MC patients. The overall 100% rate of clinical response of vasculitis, on an intention‐to‐treat basis, opens the perspective for curing the large majority of these so far difficult‐to‐treat patients. This article is protected by copyright. All rights reserved.

Source: Hepatology - August 1, 2016 Category: Internal Medicine Authors: Laura Gragnani, Marcella Visentini, Elisa Fognani, Teresa Urraro, Adriano De Santis, Luisa Petraccia, Marie Perez, Giorgia Ceccotti, Stefania Colantuono, Milica Mitrevski, Cristina Stasi, Martina Del Padre, Monica Monti, Elena Gianni, Alessandro Pulsoni, Tags: Viral Hepatitis Source Type: research